Market Estimates
Valuation Metrics
Financials
Trading Trends
RPRX News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Royalty Pharma PLC (RPRX) stock price today?
The current price of RPRX is 40.17 USD — it has decreased -0.22 % in the last trading day.
What is Royalty Pharma PLC (RPRX)'s business?
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. It collaborates with innovators from academic institutions, research hospitals and non-profits from small and mid-cap biotechnology companies to global pharmaceutical companies. It funds innovation in the biopharmaceutical industry both directly and indirectly. Directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties. Indirectly when it acquires existing royalties from the original innovators. Its portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta and Alyftrek, Johnson & Johnson’s Tremfya, GSK’s Trelegy, Roche’s Evrysdi, Servier’s Voranigo, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, and Gilead’s Trodelvy, among others, and 20 development-stage product candidates.
What is the price predicton of RPRX Stock?
Wall Street analysts forecast RPRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RPRX is 43.80 USD with a low forecast of 38.00 USD and a high forecast of 54.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Royalty Pharma PLC (RPRX)'s revenue for the last quarter?
Royalty Pharma PLC revenue for the last quarter amounts to 609.29M USD, increased 7.90 % YoY.
What is Royalty Pharma PLC (RPRX)'s earnings per share (EPS) for the last quarter?
Royalty Pharma PLC. EPS for the last quarter amounts to 0.67 USD, decreased -44.63 % YoY.
What changes have occurred in the market's expectations for Royalty Pharma PLC (RPRX)'s fundamentals?
How many employees does Royalty Pharma PLC (RPRX). have?
Royalty Pharma PLC (RPRX) has 99 emplpoyees as of January 11 2026.
What is Royalty Pharma PLC (RPRX) market cap?
Today RPRX has the market capitalization of 23.19B USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260109214739_0cb497eabb981d46c941b250989baee0.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260109150349_ff7278d56cdb1486ed7799e25c34d985.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260101000327_e1c9b20321b4c35e606e5d45fb3b3ea0.jpeg&w=384&q=75)